Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apellis Pharmaceuticals Inc COM | 2,806,980 | 2,806,980 | 0 | $168.03M | $164.99M | 20.06% | -$3.03M |
| Alpine Immune Sciences Inc | 1,241,300 | 1,241,300 | 0 | $23.66M | $49.21M | 5.98% | +$25.55M |
| Dianthus Therapeutics, Inc.(DNTH) | 554,000 | 1,380,667 | +826,667 | $5.76M | $41.42M | 5.04% | +$35.66M |
| Verona Pharma PlcADS | 2,369,000 | 2,369,000 | 0 | $47.10M | $38.12M | 4.63% | -$8.98M |
| Dyne Therapeutics, Inc.(DYN) | 792,945 | 1,242,945 | +450,000 | $10.55M | $35.29M | 4.29% | +$24.74M |
| ArriVent BioPharma, Inc.(AVBP) | 0 | 1,943,836 | +1,943,836 | $0 | $34.72M | 4.22% | +$34.72M |
| Insmed Incorporated(INSM) | 1,284,000 | 1,140,000 | -144,000 | $39.79M | $30.93M | 3.76% | -$8.86M |
| Centessa Pharmaceuticals PlcADS | 2,060,100 | 2,060,100 | 0 | $16.40M | $23.28M | 2.83% | +$6.88M |
| EyePoint, Inc.(EYPT) | 0 | 1,093,503 | +1,093,503 | $0 | $22.60M | 2.75% | +$22.60M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 2,425,000 | +2,425,000 | $0 | $22.07M | 2.68% | +$22.07M |
| Structure Therapeutics IncADS | 414,000 | 506,604 | +92,604 | $16.87M | $21.71M | 2.64% | +$4.84M |
| BridgeBio Pharma, Inc.(BBIO) | 706,800 | 690,000 | -16,800 | $28.53M | $21.33M | 2.59% | -$7.20M |
| Mind Medicine Mindmed Inc | 0 | 2,153,000 | +2,153,000 | $0 | $20.24M | 2.46% | +$20.24M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 14,718,422 | +14,718,422 | $0 | $17.51M | 2.13% | +$17.51M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 405,000 | +405,000 | $0 | $15.89M | 1.93% | +$15.89M |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 260,000 | +260,000 | $0 | $15.87M | 1.93% | +$15.87M |
| Tenaya Therapeutics, Inc.(TNYA) | 0 | 2,854,000 | +2,854,000 | $0 | $14.93M | 1.81% | +$14.93M |
| Jasper Therapeutics, Inc.(JSPR) | 0 | 500,811 | +500,811 | $0 | $14.70M | 1.79% | +$14.70M |
| Annexon, Inc.(ANNX) | 2,050,000 | 2,050,000 | 0 | $9.31M | $14.70M | 1.79% | +$5.39M |
| Cytokinetics, Incorporated(CYTK) | 116,000 | 194,000 | +78,000 | $9.68M | $13.60M | 1.65% | +$3.92M |
| Aerovate Therapeutics Inc | 403,685 | 403,685 | 0 | $9.14M | $11.94M | 1.45% | +$2.80M |
| Viridian Therapeutics, Inc.(VRDN) | 620,000 | 620,000 | 0 | $13.50M | $10.86M | 1.32% | -$2.65M |
| Gossamer Bio, Inc.(GOSS) | 9,187,883 | 9,187,883 | 0 | $8.38M | $10.84M | 1.32% | +$2.46M |
| Newamsterdam Pharma Company ORDINARY SHARES | 0 | 408,000 | +408,000 | $0 | $9.65M | 1.17% | +$9.65M |
| Glycomimetics Inc | 3,000,000 | 3,000,000 | 0 | $7.08M | $9.00M | 1.09% | +$1.92M |
| Immunovant, Inc.(IMVT) | 273,289 | 273,289 | 0 | $11.51M | $8.83M | 1.07% | -$2.68M |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 3,030,000 | +3,030,000 | $0 | $8.70M | 1.06% | +$8.70M |
| Akero Therapeutics Inc | 0 | 340,000 | +340,000 | $0 | $8.59M | 1.04% | +$8.59M |
| Ventyx Biosciences Inc | 0 | 1,501,114 | +1,501,114 | $0 | $8.26M | 1.00% | +$8.26M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 18,604,650 | +18,604,650 | $0 | $7.69M | 0.94% | +$7.69M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 0 | 250,000 | +250,000 | $0 | $7.15M | 0.87% | +$7.15M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 550,000 | +550,000 | $0 | $7.10M | 0.86% | +$7.10M |
| Silence Therapeutics plcADS(SLN) | 0 | 315,000 | +315,000 | $0 | $6.80M | 0.83% | +$6.80M |
| PepGen Inc.(PEPG) | 0 | 376,117 | +376,117 | $0 | $5.53M | 0.67% | +$5.53M |
| Vincerx Pharma Inc | 0 | 1,000,000 | +1,000,000 | $0 | $5.06M | 0.62% | +$5.06M |
| Nuvation Bio Inc.CL A(NUVB) | 1,000,000 | 1,374,870 | +374,870 | $1.51M | $5.00M | 0.61% | +$3.49M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 50,000 | 455,000 | +405,000 | $456.5K | $4.83M | 0.59% | +$4.38M |
| Mersana Therapeutics Inc | 0 | 1,000,000 | +1,000,000 | $0 | $4.48M | 0.54% | +$4.48M |
| Terns Pharmaceuticals Inc | 0 | 625,000 | +625,000 | $0 | $4.10M | 0.50% | +$4.10M |
| Fate Therapeutics, Inc.(FATE) | 0 | 520,800 | +520,800 | $0 | $3.82M | 0.46% | +$3.82M |
| Reneo Pharmaceuticals Inc | 2,250,000 | 2,250,000 | 0 | $3.60M | $3.73M | 0.45% | +$135.0K |
| Anaptysbio Inc | 120,000 | 165,000 | +45,000 | $2.57M | $3.72M | 0.45% | +$1.15M |
| Sana Biotechnology, Inc.(SANA) | 0 | 360,800 | +360,800 | $0 | $3.61M | 0.44% | +$3.61M |
| An2 Therapeutics Inc | 664,575 | 1,103,000 | +438,425 | $13.62M | $3.58M | 0.44% | -$10.03M |
| Allogene Therapeutics Inc | 0 | 720,000 | +720,000 | $0 | $3.22M | 0.39% | +$3.22M |
| Allovir Inc | 0 | 4,200,000 | +4,200,000 | $0 | $3.17M | 0.39% | +$3.17M |
| Veru Inc.(VERU) | 3,800,000 | 3,800,000 | 0 | $2.74M | $2.66M | 0.32% | -$75.6K |
| Rapt Therapeutics Inc | 292,000 | 292,000 | 0 | $7.26M | $2.62M | 0.32% | -$4.63M |
| Nkarta, Inc.(NKTX) | 0 | 240,000 | +240,000 | $0 | $2.59M | 0.32% | +$2.59M |
| Helix Acquisition Corp IiCL A | 0 | 250,000 | +250,000 | $0 | $2.59M | 0.31% | +$2.59M |
| Poseida Therapeutics Inc | 0 | 736,000 | +736,000 | $0 | $2.35M | 0.29% | +$2.35M |
| Century Therapeutics, Inc.(IPSC) | 0 | 540,000 | +540,000 | $0 | $2.26M | 0.27% | +$2.26M |
| Adicet Bio Inc | 0 | 767,799 | +767,799 | $0 | $1.80M | 0.22% | +$1.80M |
| Atyr Pharma Inc | 0 | 700,000 | +700,000 | $0 | $1.36M | 0.17% | +$1.36M |
| Autolus Therapeutics plcADS(AUTL) | 0 | 176,000 | +176,000 | $0 | $1.12M | 0.14% | +$1.12M |
| Cabaletta Bio, Inc.(CABA) | 0 | 52,000 | +52,000 | $0 | $887.1K | 0.11% | +$887.1K |
| Aclaris Therapeutics, Inc.(ACRS) | 100,000 | 0 | -100,000 | $105.0K | $0 | — | -$105.0K |
| Arcus Biosciences, Inc.(RCUS) | 1,868,000 | 0 | -1,868,000 | $35.68M | $0 | — | -$35.68M |
| Celldex Therapeutics, Inc.(CLDX) | 707,526 | 0 | -707,526 | $28.06M | $0 | — | -$28.06M |
| Cymabay Therapeutics Inc | 2,673,750 | 0 | -2,673,750 | $63.15M | $0 | — | -$63.15M |
| Gracell Biotechnologies IncADS | 596,611 | 0 | -596,611 | $5.99M | $0 | — | -$5.99M |
| Inozyme Pharma Inc | 400,000 | 0 | -400,000 | $1.70M | $0 | — | -$1.70M |
| Jasper Therapeutics, Inc.(JSPR) | 4,468,114 | 0 | -4,468,114 | $3.53M | $0 | — | -$3.53M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 25,000 | 0 | -25,000 | $738.0K | $0 | — | -$738.0K |
| Roivant Sciences Ltd.SHS(ROIV) | 2,494,000 | 0 | -2,494,000 | $28.01M | $0 | — | -$28.01M |
| Xilio Therapeutics, Inc.(XLO) | 1,785,000 | 0 | -1,785,000 | $981.8K | $0 | — | -$981.8K |